ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för adefovir. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

25 träffar

Bibliografisk träff 2018-01-01

Tenofovir disoproxil fumarate monotherapy is superior to entecavir-adefovir combination therapy in patients with suboptimal response to lamivudine-adefovir therapy for nucleoside-resistant HBV: a 96-week prospective multicentre trial.

Lee SH, Cheon GJ, Kim HS, Kim SG, Kim YS, Jeong SW, Jang JY, Kim BS, Jun BG, Don Kim Y, Jun DW, Sohn JH, Kim TY, Lee BS.

Antivir Ther · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.3851/imp3169

Bibliografisk träff 2017-04-11

Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity.

Zhao X, Sun K, Lan Z, Song W, Cheng L, Chi W, Chen J, Huo Y, Xu L, Liu X, Deng H, Siegenthaler JA, Chen L.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/srep46344

Bibliografisk träff 2017-03-18

Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.

Vincenti D, Piselli P, Solmone M, D'Offizi G, Capobianchi MR, Menzo S.

Antiviral Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.antiviral.2017.03.008

Bibliografisk träff 2017-02-03

Hypophosphatemia predicts a failure to recover from adefovir-related renal injury after dose reduction in lamivudine-resistant hepatitis B patients.

Yamamoto T, Maruyama Y, Ohashi N, Yasuda H, Shinozaki M.

Hepatol Res · journal article · DOI 10.1111/hepr.12865

Bibliografisk träff 2016-12-25

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Song BC.

Clin Mol Hepatol · editorial; comment; journal article · DOI 10.3350/cmh.2016.0108

Bibliografisk träff 2016-12-01

Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis.

Luo Q, Deng Y, Cheng F, Kang J, Zhong S, Zhang D, Zeng W.

Medicine (Baltimore) · meta-analysis; systematic review; review-article; journal article · DOI 10.1097/md.0000000000005578

Bibliografisk träff 2016-12-01

Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study.

Ruggiero G, Marrone A, Rainone I, Boemio A, Adinolfi LE, Pasquale G, Rinaldi L, Guerrera B, Andreana L, Zampino R, Thecla Study Group.

Infez Med · multicenter study; journal article

Bibliografisk träff 2016-11-25

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study).

Lee HW, Park JY, Kim BK, Kim MY, Lee JI, Kim YS, Yoon KT, Han KH, Ahn SH.

Clin Mol Hepatol · comparative study; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.3350/cmh.2016.0037

Bibliografisk träff 2016-11-17

Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.

Lin Y, Pan F, Wang Y, Chen Z, Lin C, Yao L, Zhang X, Zhou R, Pan C.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2016.5393

Bibliografisk träff 2016-11-02

Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice.

Lin MT, Yen YH, Tsai MC, Tseng PL, Chang KC, Wu CK, Hu TH.

PLoS One · comparative study; research-article; journal article · DOI 10.1371/journal.pone.0165416

Bibliografisk träff 2016-11-01

Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B.

Li Z, Shen C, Wang Y, Wang W, Zhao Q, Liu Z, Wang Y, Zhao C.

Medicine (Baltimore) · research-article; multicenter study; journal article · DOI 10.1097/md.0000000000005264

Bibliografisk träff 2016-10-15

Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir.

Hiramatsu R, Ubara Y, Sawa N, Hasegawa E, Kawada M, Imafuku A, Sumida K, Hoshino J, Takaichi K.

Intern Med · journal article; case reports; case-report · DOI 10.2169/internalmedicine.55.6806

Bibliografisk träff 2016-09-25

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment.

Kim HJ, Park SK, Yang HJ, Jung YS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Choi KY.

Clin Mol Hepatol · comparative study; research-article; journal article · DOI 10.3350/cmh.2016.0019

Bibliografisk träff 2016-09-21

Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors.

Wei Z, He JW, Fu WZ, Zhang ZL.

Bone · journal article · DOI 10.1016/j.bone.2016.09.017

Bibliografisk träff 2016-09-20

Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients.

Pereira-Gómez M, Bou JV, Andreu I, Sanjuán R.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0163363

Bibliografisk träff 2016-08-29

Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis.

Tian L, Fu Q, Huang F.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2016.3623

Bibliografisk träff 2016-07-02

Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.

Laho T, Clarke JD, Dzierlenga AL, Li H, Klein DM, Goedken M, Micuda S, Cherrington NJ.

Biochem Pharmacol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bcp.2016.07.001

Bibliografisk träff 2016-04-14

De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.

Yang S, Xing H, Wang Q, Wang X, Liu S, Cheng J.

Ann Clin Microbiol Antimicrob · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12941-016-0138-0

Bibliografisk träff 2013-12-12

In vitro evaluation of 9-(2-phosphonylmethoxyethyl)adenine ester analogues, a series of anti-HBV structures with improved plasma stability and liver release.

Liao S, Fan SY, Liu Q, Li CK, Chen J, Li JL, Zhang ZW, Zhang ZQ, Zhong BH, Xie JW.

Arch Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s12272-013-0300-6

Bibliografisk träff 2012-09-01

Extent of intramolecular π-stacks in aqueous solution in mixed-ligand copper(II) complexes formed by heteroaromatic amines and several 2-aminopurine derivatives of the antivirally active nucleotide analog 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

Gómez-Coca RB, Blindauer CA, Sigel A, Operschall BP, Holý A, Sigel H.

Chem Biodivers · research support, non-u.s. gov't; journal article · DOI 10.1002/cbdv.201200022

Bibliografisk träff 2005-04-01

Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.

Herreros de Tejada Echanojáuregui A, Moreno Planas JM, Rubio González E, Portero Azorin F, López Monclús J, Revilla Negro J, Lucena de la Poza JL, Sánchez Turrión V, Barrios Peinado C, Cuervas-Mons Martínez V.

Transplant Proc · journal article · DOI 10.1016/j.transproceed.2005.02.031

Bibliografisk träff 2004-02-20

Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.

Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang CR, Gibbs CS, Tang WJ.

Proc Natl Acad Sci U S A · research support, u.s. gov't, p.h.s.; research-article; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1073/pnas.0306552101

Bibliografisk träff 2003-12-01

Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes.

Köck J, Baumert TF, Delaney WE, Blum HE, von Weizsäcker F.

Hepatology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.hep.2003.09.009

Bibliografisk träff 2002-02-01

Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.

Delmas J, Schorr O, Jamard C, Gibbs C, Trépo C, Hantz O, Zoulim F.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.46.2.425-433.2002

Bibliografisk träff 1999-12-01

Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde.

Sparidans RW, Veldkamp A, Hoetelmans RM, Beijnen JH.

J Chromatogr B Biomed Sci Appl · journal article · DOI 10.1016/s0378-4347(99)00447-8